We are live on ! Find out more
NTUS

Natus Medical Inc

Delisted

NTUS was delisted on the 20th of July, 2022.

175 hedge funds and large institutions have $1.12B invested in Natus Medical Inc in 2018 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 55 increasing their positions, 66 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

10% more capital invested

Capital invested by funds: $1.02B → $1.12B (+$98.4M)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

5% less funds holding

Funds holding: 184175 (-9)

13% less call options, than puts

Call options by funds: $2.38M | Put options by funds: $2.72M

17% less repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 66

32% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 28

Holders
175
Holders Change
-9
Holders Change %
-4.89%
% of All Funds
4.01%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
19
Increased
55
Reduced
66
Closed
28
Calls
$2.38M
Puts
$2.72M
Net Calls
-$342K
Net Calls Change
-$3.89M
Name Holding Trade Value Shares
Change
Change in
Stake
PCM
26
Peregrine Capital Management
Minnesota
$8.26M -$1.94M -55,232 -19%
BCM
27
Beddow Capital Management
Wyoming
$7.36M -$27.2K -775 -0.4%
Wells Fargo
28
Wells Fargo
California
$7.34M +$533K +15,208 +8%
ACH
29
ArrowMark Colorado Holdings
Colorado
$7.2M -$8.41M -239,780 -53%
HAM
30
Hillcrest Asset Management
Texas
$6.93M -$70.5K -2,010 -1%
Deutsche Bank
31
Deutsche Bank
Germany
$6.43M -$730K -20,826 -10%
Norges Bank
32
Norges Bank
Norway
$6.14M -$8.91M -254,059 -59%
Charles Schwab
33
Charles Schwab
California
$6.06M +$550K +15,684 +10%
WCM Investment Management
34
WCM Investment Management
California
$6.06M -$832K -23,736 -12%
CI
35
Cambiar Investors
Colorado
$5.32M -$1.16M -33,013 -18%
USAA
36
United Services Automobile Association
Texas
$5.22M -$5.65M -161,080 -52%
SO
37
STRS Ohio
Ohio
$4.83M
Goldman Sachs
38
Goldman Sachs
New York
$4.46M -$168K -4,789 -4%
PP
39
PDT Partners
New York
$3.84M -$611K -17,444 -14%
Nordea Investment Management
40
Nordea Investment Management
Sweden
$3.03M -$436K -12,431 -12%
QI
41
QS Investors
New York
$2.84M
RhumbLine Advisers
42
RhumbLine Advisers
Massachusetts
$2.81M +$111K +3,172 +4%
California Public Employees Retirement System
43
California Public Employees Retirement System
California
$2.79M -$100K -2,866 -3%
New York State Teachers Retirement System (NYSTRS)
44
New York State Teachers Retirement System (NYSTRS)
New York
$2.65M
Morgan Stanley
45
Morgan Stanley
New York
$2.58M -$113K -3,214 -4%
TCIM
46
TIAA CREF Investment Management
New York
$2.52M -$97.9K -2,794 -4%
PPA
47
Parametric Portfolio Associates
Washington
$2.5M -$61.9K -1,766 -2%
Legal & General Group
48
Legal & General Group
United Kingdom
$2.46M +$52.9K +1,508 +2%
BCC
49
Bridge City Capital
Oregon
$2.38M -$80.4K -2,293 -3%
MAP
50
Moody Aldrich Partners
Massachusetts
$2.35M +$1.02M +29,190 +75%

NTUS Hedge Fund Activity: Q2 2018 in Review

175 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Natus Medical Inc (NTUS) for Q2 2018, worth a combined $1.12B — up 9.7% from $1.02B a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of NTUS and 19 opened new positions — a net loss of 9 holders — while 66 trimmed existing stakes and 55 added.

The largest buyer was Eagle Asset Management, adding an estimated $44.9M. The largest seller was Corsair Capital Management, cutting an estimated $18.8M.

  • 175 institutional investors held Natus Medical Inc (NTUS) as of Q2 2018, down from 184 in Q1 2018.
  • Funds reported $1.12B of Natus Medical Inc stock for Q2 2018, up 9.7% quarter-over-quarter.
  • 19 funds opened new Natus Medical Inc positions in Q2 2018 and 28 closed out, a net change of -9 holders.
  • The largest Natus Medical Inc buyer in Q2 2018 was Eagle Asset Management, an estimated $44.9M added.
  • The largest Natus Medical Inc seller in Q2 2018 was Corsair Capital Management, an estimated $18.8M sold.

Based on aggregated 13F filings for Q2 2018.